Zack Raborn
About Zack Raborn
Zack Raborn is a Senior Manager of Innovation Partnerships at Cardea Bio Inc., where he focuses on developing next-generation diagnostic solutions. He has a diverse background in finance, accounting, and biotechnology, having worked in various roles across multiple organizations.
Current Role at Cardea Bio Inc.
Zack Raborn serves as the Senior Manager of Innovation Partnerships at Cardea Bio Inc., a position he has held since 2021. In this role, he manages partnerships that focus on next-generation onsite diagnostics and monitoring solutions within the life science and healthcare sectors. His responsibilities include contributing to the development of digital graphene biosensors for rapid, portable multi-analyte testing. Prior to this, he was the Manager of Innovation Partnerships at Cardea Bio from 2019 to 2021.
Previous Experience in Finance and Taxation
Zack Raborn has a background in finance and taxation, having worked as a Portfolio Analyst at Frontier Capital for six months in 2016. He also served as an Experienced Associate at PriceWaterhouseCoopers, focusing on Private Equity Taxation and F500 SEC Audits for ten months in 2015. Additionally, he worked as a Tax Analyst at McArthur, McKeiver, & Vaughan, PLLC for three months in 2016.
Educational Background
Zack Raborn earned a Master's Degree in Accounting from Clemson University in 2014, following his completion of a Bachelor's degree in Economics with a Finance minor from the same institution in 2013. He also studied Chemistry and Biotechnology at San Diego Miramar College from 2018 to 2019, achieving a GPA of 3.96+. Furthermore, he completed Levels 1 and 2 of the CFA Program at the CFA Institute.
Experience at Clemson University
Zack Raborn has held multiple roles at Clemson University. He graduated with a Master's in Professional Accounting in December 2014 and worked there for 11 months. He also completed his undergraduate studies at Clemson, where he graduated in May 2013 with a BS in Economics and a Finance minor, studying from 2009 to 2013.
Contributions to Biosensor Development
At Cardea Bio Inc., Zack Raborn played a role in customizing modular infrastructure for specific product applications. His work has been integral to the company's focus on innovation partnerships, particularly in the development of digital graphene biosensors aimed at enhancing diagnostic capabilities.